Zavation acquires ChoiceSpine to expand spinal implant portfolio
Zavation Medical Products LLC, has acquired ChoiceSpine Holdings, Inc, Knoxville, Tennessee, USA, through an undisclosed transaction. Zavation is a portfolio company of Gemspring Capital and a designer and manufacturer of spinal implants, interventional spine products and biologics, based in Flowood, Mississippi.
Founded in 2006, ChoiceSpine has developed a portfolio of spinal implant and instrumentation systems covering cervical, thoracolumbar and interbody applications. The company focuses on user-driven design, supported by a national distributor network.
The acquisition expands Zavation’s product portfolio and commercial reach across inpatient and outpatient settings. The company stated that its vertically integrated manufacturing platform will support further product development and reduce time to market. ChoiceSpine will continue to operate under its existing brand as integration progresses.
ADVERTISE WITH METAL AM
REACH ENGINEERS, DECISION-MAKERS AND INDUSTRY LEADERS SHAPING TECHNOLOGY ADOPTION
| Request a Media Pack |
Zavation has also appointed Derek Kuyper as Chief Executive Officer of the combined organisation. Kuyper has over fifteen years of experience in the spinal device sector, spanning sales, marketing, product management and commercial operations. He previously served as Chief Commercial Officer at Zavation, where he was responsible for the company’s commercial strategy and distributor network.
Steve Ainsworth, Co-President of ChoiceSpine, will remain with the company to support integration activities. Chirag Hirawat, Principal at Gemspring Capital, stated that the acquisition strengthens Zavation’s market position and supports its long-term growth strategy.
“I am honoured to step into the role of CEO and lead Zavation’s next phase of growth,” stated Kuyper. “The acquisition of ChoiceSpine advances our strategy to build a scaled, innovation-driven spinal platform. ChoiceSpine’s complementary portfolio, strong distributor relationships, and commitment to user-driven design align closely with our values and enhance our ability to serve customers across care settings. We look forward to welcoming the ChoiceSpine team and building on our combined momentum.”
Hirawat, Principal at Gemspring Capital, added, “ChoiceSpine is a highly complementary addition that strengthens Zavation’s competitive position. We are excited to support Derek and the leadership team as they execute on the company’s long-term growth strategy.”
ChoiceSpine offers a range of additively manufactured product lines specifically designed for surgeons, which are said to prioritise safety, efficiency, and ease of use. By fostering collaboration with physicians and industry partners, Choice Spine aims to deliver on product commitments, conduct innovative research and development, and offer up-to-date technology to the spinal market.
